Observational study identifies drug that improves survival in sickest COVID-19 patients

August 18, 2020 – Edison, NJ — Researchers at Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to…

Details

Clinical and sociodemographic features of early COVID-19 patients

Clinical and sociodemographic features of early COVID-19 patients in Massachusetts: MGH study suggests vulnerable populations are hardest hit BOSTON – Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.…

Details

Increasing graduation rates of students of color with more faculty of color

A new analysis published in Public Administration found that student graduation rates improve as more faculty employed by a college or university share sex and race/ethnic identities with students. The analysis focuses on the concept of intersectionality, which seeks to understand how aspects of a person’s social and political identities–such as gender, race, class, sexuality,…

Details